Literature DB >> 23125539

A step towards the cure of Burkitt's lymphoma in developing countries.

Claudete Esteves Klumb1.   

Abstract

Entities:  

Year:  2012        PMID： 23125539      PMCID： PMC3486821          DOI： 10.5581/1516-8484.20120087

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN： 1516-8484


× No keyword cloud information.
  11 in total

Review 1.  Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.

Authors:  Mitchell S Cairo; Bertrand Coiffier; Alfred Reiter; Anas Younes
Journal:  Br J Haematol       Date:  2010-03-16       Impact factor: 6.998

Review 2.  Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.

Authors:  Rodney R Miles; Staci Arnold; Mitchell S Cairo
Journal:  Br J Haematol       Date:  2012-01-20       Impact factor: 6.998

3.  Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

Authors:  A Reiter; M Schrappe; M Tiemann; W D Ludwig; E Yakisan; M Zimmermann; G Mann; A Chott; W Ebell; T Klingebiel; N Graf; B Kremens; S Müller-Weihrich; H J Plüss; F Zintl; G Henze; H Riehm
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

4.  Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.

Authors:  Mitchell S Cairo; Mary Gerrard; Richard Sposto; Anne Auperin; C Ross Pinkerton; Jean Michon; Claire Weston; Sherrie L Perkins; Martine Raphael; Keith McCarthy; Catherine Patte
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

5.  Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.

Authors:  Catherine Patte; Anne Auperin; Mary Gerrard; Jean Michon; Ross Pinkerton; Richard Sposto; Claire Weston; Martine Raphael; Sherrie L Perkins; Keith McCarthy; Mitchell S Cairo
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

6.  Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.

Authors:  M S Cairo; M D Krailo; M Morse; R J Hutchinson; R E Harris; C R Kjeldsberg; M E Kadin; E Radel; L J Steinherz; E Morris; J L Finlay; A T Meadows
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

7.  Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.

Authors:  Andrea Meinhardt; Birgit Burkhardt; Martin Zimmermann; Arndt Borkhardt; Udo Kontny; Thomas Klingebiel; Frank Berthold; Gritta Janka-Schaub; Christoph Klein; Edita Kabickova; Wolfram Klapper; Andishe Attarbaschi; Martin Schrappe; Alfred Reiter
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

8.  The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.

Authors:  Wilhelm Woessmann; Kathrin Seidemann; Georg Mann; Martin Zimmermann; Birgit Burkhardt; Ilske Oschlies; Wolf-Dieter Ludwig; Thomas Klingebiel; Norbert Graf; Bernd Gruhn; Heribert Juergens; Felix Niggli; Reza Parwaresch; Helmut Gadner; Hansjoerg Riehm; Martin Schrappe; Alfred Reiter
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

9.  Towards curative therapy in burkitt lymphoma: the role of early african studies in demonstrating the value of combination therapy and CNS prophylaxis.

Authors:  Ian Magrath
Journal:  Adv Hematol       Date:  2012-01-11

10.  Clinical course and prognostic factors of children with Burkitt's lymphoma in a developing country: the experience of a single centre in Brazil.

Authors:  Keyla Christy Christine Mendes Sampaio Cunha; Maria Christina Lopes Araujo Oliveira; Ana Cecília Silva Gomes; Lucia Porto Fonseca de Castro; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.